Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome

BACKGROUND: Advanced treatment of pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) is increasingly applied worldwide following the—mainly Western world based—international PAH-CHD guidelines. However, studies comparing clinical presentation and outcome after the initiation of...

Descripción completa

Detalles Bibliográficos
Autores principales: van Riel, A. C. M. J., Schuuring, M. J., van Hessen, I. D., van Dijk, A. P. J., Hoendermis, E. S., Yip, J. W., Mulder, B. J. M., Bouma, B. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2016
Materias:
Original Article - ICIN
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887299/
https://www.ncbi.nlm.nih.gov/pubmed/26984567
http://dx.doi.org/10.1007/s12471-016-0820-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887299/
https://www.ncbi.nlm.nih.gov/pubmed/26984567
http://dx.doi.org/10.1007/s12471-016-0820-z

Ejemplares similares